This study demonstrated that sulfonylureas were linked to adecreased risk of both stroke and ischemic stroke, which is consistent with ourfindings, whereby elevated KCNJ11 (the target gene of sulfonylureas)expression is associated with an increased risk of AIS [27]. This evidence concerns the gene KCNJ11 and ischemic stroke.